CSL Limited (ASX:CSL)
Pharmaceuticals, Biotechnology & Life Sciences
share price: (EoD)
earnings per share:
dividends per share:
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
CSL Limited (ASX:CSL) share price
CSL Limited (ASX:CSL) passive income
CSL Limited (ASX:CSL) share price news
ASX Growth Shares
Red, orange and green flags: 10 things to know before share investing ft. Danielle Ecuyer
Danielle Ecuyer of Shareplicity joins Owen Rask and Kate Campbell on this special episode of The Australian Finance Podcast to share 10 things to look for when researching ASX and global shares/companies.
November 7, 2022
ASX Growth Shares
S&P/ASX 200 price bounces, Rio Tinto circles Turquoise Hill
The S&P/ASX 200 (INDEXASX: XJO) managed a small gain on Wednesday, adding 0.1 per cent, as strength in the energy and materials sectors offset losses in property. Rio Tinto Limited’s (ASX:RIO) interest in Turquoise Hill has got investors thinking.
November 3, 2022
ASX Growth Shares
CSL (ASX:CSL) share price in focus after mRNA vaccine deal
The CSL Limited (ASX: CSL) share price is in focus today after the biotech giant made a mRNA vaccine announcement.
November 2, 2022
ASX Bank Shares
Finding the ASX’s 10 best companies, failure, grit, the top investor letters & so much more | Nathan Bell from Intelligent Investor
Nathan Bell, CFA is Head of Portfolio Management at The Intelligent Investor. Investor Nathan Bell joins Owen Rask on The Australian Investors Podcast.
October 24, 2022
ASX Growth Shares
ASX reports blitz: CSL, SEK, VCX, RBL, CGF, BHP & CAR
Drew Meredith, CFP and Owen Rask are back on The Australian Investors Podcast for ASX reporting season, covering CSL Limited (ASX:CSL), BHP Group Ltd (ASX:BHP) and more.
August 20, 2022
ASX Growth Shares
CSL (ASX:CSL) share price on watch after $2.25 billion net profit in FY22
The CSL Limited (ASX:CSL) share price is in focus after the ASX healthcare share reported its FY22 result.
August 17, 2022
ASX Bank Shares
RBA rate rises but S&P/ASX 200 (XJO) pushes higher
The S&P/ASX 200 (NDEXASX:XJO) price bounced on Tuesday, with the All Ordinaries (ASX:XAO) price also overcoming RBA interest rate rises. CSL Limited (ASX:CSL) shares popped.
August 3, 2022
ASX Share Ideas
Deal done: Why the CSL (ASX:CSL) share price is in focus
The CSL Limited (ASX:CSL) share price is making headlines today after ASX healthcare share announced it can finally acquire Vifor.
August 2, 2022
Australian Investors Podcast
Psychology, gambling, investing & writing, a discussion with Graham Witcomb, CFA
Graham Witcomb, CFA of The Intelligent Investor joins Owen Rask on The Australian Investors Podcast to talk markets, psychology, life & more.
July 23, 2022
